Magnevist is a brand name of gadopentetate dimeglumine, approved by the FDA in the following formulation(s):
MAGNEVIST (gadopentetate dimeglumine - injectable; injection)
Manufacturer: BAYER HLTHCARE
Approval date: June 2, 1988
Strength(s): 469.01MG/ML [RLD]
Manufacturer: BAYER HLTHCARE
Approval date: March 10, 2000
Strength(s): 469.01MG/ML [RLD]
Has a generic version of Magnevist been approved?
No. There is currently no therapeutically equivalent version of Magnevist available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Magnevist. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Gadolinium chelates for magnetic resonance imaging
Patent 5,362,475
Issued: November 8, 1994
Inventor(s): Gries; Heinz & Rosenberg; Douwe & Weinmann; Hanns-Joachim & Speck; Ulrich & Mutzel; Wolfgang & Hoyer; Georg-Alexander & Pfeiffer, deceased; Heinrich & Renneke; Franz-Josef
Assignee(s): Schering Aktiengesellschaft
A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more Gadolinium ions and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.Patent expiration dates:
- November 8, 2011
- November 8, 2011
See also...
- Magnevist Consumer Information (Drugs.com)
- Magnevist Consumer Information (Wolters Kluwer)
- Magnevist Consumer Information (Cerner Multum)
- Magnevist Advanced Consumer Information (Micromedex)
- Gadopentetate Dimeglumine Consumer Information (Wolters Kluwer)
- Gadopentetate dimeglumine Consumer Information (Cerner Multum)
- Gadopentetate Intravenous Advanced Consumer Information (Micromedex)
No comments:
Post a Comment